Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 2, 2002

View Archived Issues

Antitumor activity of R-116010 is due to inhibition of all-trans-retinoic acid metabolism

Bivalirudin + abciximab for percutaneous coronary revascularization

Androgen suppression improves outcomes in the radiotherapy of locally advanced prostate cancer

Discovery Labs and Aerogen collaborate on aerosol-delivered surfactants

Genzyme Biosurgery and Myosix to advance autologous cell therapy for heart disease

BioTransplant revises development strategy for Allomune system

Phase III results of CDP-571 in Crohn's disease

TLK-19781 to enter clinic at Telik

Phase II/III Esterom trial completes enrollment

Inhibitors of protein kinase C and/or glycogen synthase kinase-3 in Ortho-McNeil patent

aaiPharma and Tanabe Seiyaku form joint venture

Cubist awarded SBIR grant for anthrax target research

Triangle reacquires product rights from Abbott

New carbapenem antibiotics emerge from Sumitomo R&D

Ortho-McNeil presents novel GnRH antagonists for infertility, prostate disorders, etc.

Selective adenosine A1 agonists for cardiovascular ischemic disorders claimed by GSK

Novel delta-opioid agonists/antagonists identified at Ortho-McNeil

P&G scientists describe novel benzimidazole with antitumor/antiviral activity

Iodinated alkenes with potential as X-ray contrast agents in Nycomed Imaging patent

Novel antithrombin agents prepared and tested at Servier

Prous Science webcasts the Mild Cognitive Impairment (MCI): State-of-the-Art Seminar

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...